We observed several years ago that CD71‐positive bone marrow erythroid progenitors from MDS patients fail to activate signal transducer and activator of transcription 5 (STAT5) after in vitro EPO stimulation, and this lack of activation correlates with clinical unresponsiveness to ESAs.22 The gene discussed is EPO; the disease is myelodysplastic syndrome.